New drug reduces transplant and mortality rates significantly in patients with hepatitis C

(Intermountain Medical Center) Patients with hepatitis C who suffer from advanced stages of liver disease have renewed hope, thanks to findings by researchers who have discovered that a new drug significantly reduces their risk of death and need for transplantation.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news